EFSA is standing by a CLA-weight loss health claim rejection despite an appeal that accused it of failing to evaluate submitted efficacy data from joint applicants BASF and Stepan Lipid Nutrition.
from NutraIngredients RSS http://ift.tt/1ICXJ6Z
via IFTTT